Vyhláška Ministerstva zdravotnictví, kterou se mění vyhláška Ministerstva zdravotnictví č. 57/1997 Sb., kterou se stanoví léčivé přípravky plně hrazené z veřejného zdravotního pojištění a výše úhrad jednotlivých léčivých látek, ve znění pozdějších předpisů
| 208.1 | G03CA | přirozené a semisyntetické estrogeny prosté, mestranol | p.o. | 0.15 | MG | 3,76 | P |
|---|---|---|---|---|---|---|---|
| 208.2 | G03CA57 | přírodní konj. estrogeny (do 625 RG včetně v jedné tabletě nebo tobolce) | p.o. | 625 | RG | 6,00 | P |
| 83387 | OESTROFEMINAL 0.6 | cps 21x0.6mg | MAC | D | |||
| 208.3 | G03CA03 | estradiol (do 1 mg v jedné tabletě včetně) | p.o. | 2 | MG | 9,00 | P |
| 208.4 | G03CA03 | estradiol (nad 1 mg do 2 mg v jedné tabletě včetně) | p.o. | 2 | MG | 6,00 | P |
| 208.5 | G03CA03 | estradiol (nad 2 mg v jedné tabletě) | p.o. | 2 | MG | 4,40 | P |
| 208.6 | G03CA03 | estradiol (s uvolněním méně než 50 RG/den, v rámci 28. denního cyklu) | transd. | 1 | DF | 4,40 | P |
| 208.7 | G03CA03 | estradiol (s uvolněním od 50 do 99 RG včetně /den, v rámci 28. denního cyklu) | transd. | 1 | DF | 6,00 | P |
| 57473 | DERMESTRIL-SEPTEM 50 | tts emp 4x5mg | LHM | D | |||
| 208.8 | G03CA03 | estradiol (s uvolněním 100 a více RG/den, v rámci 28. denního cyklu) | transd. | 1 | DF | 9,00 | P |
| 208.9 | G03CA03 | estradiol (lékové formy gelů) | transd. | 1,5 | MG | 5,87 | P |
| 76922 | OESTROGEL | gel 1x80gm | LBE | F | |||
| 208.10 | G03CA03 | estradiol | vag. | 25 | RG | 5,87 | P |
| 208.11 | G03CA04 | estriol | p.o. | 2 | MG | 6,00 | P |
| 208.12 | G03CA04 | estriol (lékové formy vaginálních krémů) | vag. | 0.2 | MG | 3,08 | P |
| 97170 | OVESTIN | crm 15gm+aplikator | ORG | NL | |||
| 98182 | OVESTIN | crm vag 1x 15gm+aplikator | ORG | IRL | |||
| 208.13 | G03CA04 | estriol (lékové formy vaginálních tablet, do 0,5 mg včetně) | vag. | 0.2 | MG | 5,87 | P |
| 208.14 | G03CA04 | estriol (lékové formy vaginálních tablet, nad 0,5 mg) | vag. | 0.2 | MG | 1,22 | P |
| 097590 | ORTHOGYNEST D | sub vag 6 | CIL | CH | |||
| 208.15 | G03CA57 | přírodní konj. estrogeny (nad 625 RG v jedné tabletě nebo tobolce) | p.o. | 625 | RG | 4,34 | P |
| 09467 | OESTROFEMINAL 1.25 | cps 21x1.25mg | MAC | D | |||
| 208.16 | G03CA03 | estradiol (lékové formy vaginálních krémů) | vag. | 0.2 | MG | 3,08 | P |
| 209 | G03CA | přirozené a semisyntetické estrogeny | parent. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 209.1 | G03CA03 | estradiol | parent. | 1 | MG | 4,35 | |
| 00364 | AGOFOLLIN | inj 5x1ml/5mg | BTA | SK | |||
| 00365 | AGOFOLLIN-DEPOT | inj 1x2ml/10mg | BTA | SK | |||
| 56188 | AGOFOLLIN DEPOT | inj 5x2ml/10mg | BTA | SK | |||
| 209.2 | G03CA03 | estradiol valerat | parent. | 1 | MG | 2,40 | |
| 00529 | NEOFOLLIN | inj 5x1ml/5mg | BTA | SK | |||
| 209.3 | G03CA03 | estradiol implantát | parent. | 1 | DF | 1095,00 | |
| 209.4 | G03CA04 | estriol | parent. | 2 | MG | 4,30 | |
| 210 | G03D | progestiny | p.o. | L/GYN,URN,END,INT, SEX | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 210.1 | G03DA02 | medroxyprogesteron | p.o. | 5 | MG | 3,62 | L/GYN,URN,END, INT,SEX |
| 210.2 | G03DA04 | progesteron | p.o. | 0.3 | GM | 17,40 | L/GYN,URN,END, INT,SEX |
| 210.3 | G03DB01 | dydrogesteron | p.o. | 10 | MG | 3,81 | L/GYN,URN,END, INT,SEX |
| 210.4 | G03DC02 | norethisteron | p.o. | 5 | MG | 2,88 | L/GYN,URN,END, INT,SEX |
| 01939 | NORETHISTERON SLOVAKOFARMA | tbl 30x5mg | SLO | SK | |||
| 210.5 | G03DC03 | lynestrenol | p.o. | 5 | MG | 2,88 | L/GYN,URN,END, INT,SEX |
| 210.6 | G03DC05 | tibolon | p.o. | 2.5 | MG | 18,00 | P |
Léčbu tibolonem ordinuje gynekolog k léčbě estrogen deficitního syndromu tam, kde jsou jiné hormonální přípravky kontraindikovány nebo kde jiné hormonální přípravky pacientka objektivně nesnáší.
| 211 | G03D | progestiny | parent. | L/GYN,URN,SEX | |||
|---|---|---|---|---|---|---|---|
| 211.1 | G03DA03 | hydroxyprogesteron | parent. | 10 | MG | 1,76 | L/GYN,URN,SEX |
| 00531 | NEOLUTIN FORTE | inj 5x1 ml/125mg | SPX | CZ | |||
| 211.2 | G03DA04 | progesteron (depotní lékové formy) | parent. | 5 | MG | 4,01 | L/GYN,URN,SEX |
| 00367 | AGOLUTIN-DEPOT | inj 1x2ml/50mg | BTA | SK | |||
| 211.3 | G03DA04 | progesteron | parent. | 5 | MG | 1,08 | L/GYN,URN,SEX |
| 02094 | AGOLUTIN | inj 5x2ml/60mg | BTA | SK | |||
| 212 | G03E | androgeny a ženské pohlavní hormony | parent. | L/GYN,END,SEX | |||
| 212.1 | G03EA02 | testosteron a estrogen | parent. | 1 | DF | 22,34 | L/GYN,END,SEX |
| 00464 | FOLIVIRIN | inj 5x2ml | BTA | SK | |||
| 212.2 | G03EA03 | prasteron enantat/estradiol valerat | parent. | 1 | DF | 73,32 | L/GYN,END,SEX |
| 213 | G03F | progestiny a estrogeny | p.o. | P |
Léčbu ordinuje gynekolog, sexuolog nebo endokrinolog:
léčba postmenopausálního vegetativního a estrogen-deficitního syndromu.
| 213.1 | G03FA01 | norethisteron a estrogen, fixní kombinace s obsahem 2 MG estradiolu v jedné tabletě | p.o. | 1 | DF | 6,84 | P |
|---|---|---|---|---|---|---|---|
| 213.2 | G03FA01 | norethisteron a estrogen, fixní kombinace s obsahem 1 MG estradiolu v jedné tabletě | p.o. | 1 | DF | 5,50 | P |
| 213.3 | G03FA01 | norethisteron a estrogen, fixní kombinace | transd. | 1 | DF | 6,84 | P |
| 213.4 | G03FA12 | medroxyprogesteron a estrogen, fixní kombinace | p.o. | 1 | DF | 6,84 | P |
| 53690 | PREMELLA 2.5 | tbl obd 1x28 | WYM | IRL | |||
| 53691 | PREMELLA 2.5 | tbl obd 3x28 | WYM | IRL | |||
| 53692 | PREMELLA 5 | tbl obd 1x28 | WYM | IRL | |||
| 53693 | PREMELLA 5 | tbl obd 3x28 | WYM | IRL | |||
| 213.5 | G03FB | gestageny a estrogeny, sekvenční přípravky | p.o. | 0.75 | DF | 5,08 | P |
| 213.6 | G03FB05 | norethisteron a estrogen, sekvenční přípravky | p.o. | 1 | DF | 6,84 | P |
| 213.7 | G03FB05 | norethisteron a estrogen, sekvenční přípravky | transd. | 1 | DF | 6,84 | P |
| 213.8 | G03FB06 | medroxyprogesteron a estrogen, sekvenční přípravky | p.o. | 0.75 | DF | 5,08 | P |
| 54310 | DIVINA | tbl 3x21 (=63) | ORN | DK | |||
| 54309 | DIVINA | tbl 1x21 | ORN | DK | |||
| 45182 | CYCLO-PREMELLA | tbl obd 1x28 | WYM | IRL | |||
| 45183 | CYCLO-PREMELLA | tbl obd 3x28 | WYM | IRL | |||
| 213.9 | G03FB08 | dydrogesteron a estrogen, sekvenční kombinace | p.o. | 0.75 | DF | 5,08 | P |
| 213.10 | G03FB09 | levonorgestrel a estrogen, sekvenční přípravky | transd. | 1 | DF | 6,84 | P |
| 213.11 | G03FB09 | levonorgestrel a estrogen, sekvenční kombinace | p.o. | 0,75 | DF | 5,08 | P |
| 67425 | CYCLO-MENORETTE | tbl obd 3x21 (=63) | WYE | D | |||
| 84582 | CYCLOOSTROGYNAL | drg 21 | ASH | D | |||
| 84583 | CYCLOOSTROGYNAL | drg 3x21(=63) | ASH | D | |||
| 213.12 | G03HB01 | cyproteron/estradiol | p.o. | 0.75 | DF | 5,08 | P |
| 214 | G03GA | gonadotrofin (choriový) | parent. | L/GYN,END,PDD,SEX | |||
| 214.1 | G03GA01 | choriový gonadotrofin (do 500 U v 1 ampuli včetně) | parent. | 250 | U | 24,59 | L/GYN,END,PDD, SEX |
| 10809 | PREGNYL | inj 3x500ut+solv. | ORG | NL | |||
| 214.2 | G03GA01 | choriový gonadotrofin (nad 500 U do 1500 U v 1 ampuli včetně) | parent. | 250 | U | 15,45 | L/GYN,END,PDD, SEX |
| 11951 | PREGNYL | inj 3x1500ut+solv. | ORG | NL | |||
| 214.3 | G03GA01 | choriový gonadotrofin (nad 1500 U v 1 ampuli) | parent. | 250 | U | 11,05 | L/GYN,END,PDD, SEX |
| 96314 | PREGNYL | inj 3x5000ut+solv. | ORG | NL | |||
| 215 | G03GA | gonadotrofin (lidský) | parent. | Z | |||
| 215.1 | G03GA02 | gonadotrofin lidský | parent. | 75 | U | 329,64 | Z |
| 12979 | MENOGON | inj sic 10+10xsolv. | FEI | D | |||
| 43727 | MERIONAL 75 M.J. | inj sic 1x75ut+solv | IBS | CH | |||
| 12979 | MENOGON | inj sic 10+10xsolv. | FEI | D | |||
| 215.2 | G03GA04 | urofollitrofin | parent. | 75 | U | 400,81 | Z |
| 56473 | METRODIN 75 | inj sic 1x75ut+solv | SRO | I | |||
| 56474 | METRODIN 75 | inj sic 10x75ut+sol | SRO | I | |||
| 43723 | FOSTIMON 75 M.J. | inj sic 1x75ut+solv | IBS | CH | |||
| 43724 | FOSTIMON 75 M.J | inj sic 10x75ut+sol | IBS | CH | |||
| 215.3 | G03GA06 | folitrofin beta | parent. | 75 | U | 733,19 | Z |
| 215.4 | G03GA04 | urofollitrofin vysoce čištěný | parent. | 75 | U | 488,79 | Z |
| 215.5 | G03GA05 | folitrofin alfa | parent. | 75 | U | 733,19 | Z |
| 216 | G03GB | syntetické stimulátory ovulace | p.o. | L/GYN,END,SEX | |||
| 216.1 | G03GB02 | klomifen | p.o. | 9 | MG | 1,32 | L/GYN,END,SEX, URN |
| 83672 | CLOMHEXAL 50 | tbl 10x50mg | HEX | D | |||
| 217 | G03HA | antiandrogeny | p.o. | ||||
| 217.1 | G03HA01 | cyproteron (do 10 mg v jedné tabletě včetně) | p.o. | 0.1 | GM | 166,20 | |
| 77006 | ANDROCUR 10MG | tbl 15x10mg | SAG | D | |||
| 217.2 | G03HA01 | cyproteron (nad 10 mg v jedné tabletě) | p.o. | 0.1 | GM | 61,80 | |
| 97862 | ANDROCUR | tbl 20x50mg | SAG | D | |||
| 03783 | ANDROCUR | tbl 50x50mg | SAG | D | |||
| 59354 | ANDROCUR 100 | tbl obd 50x100mg | SUE | F | |||
| 218 | G03HA | antiandrogeny | parent. | L/PSY,SEX | |||
| 218.1 | G03HA01 | cyproteron | parent. | 0.1 | GM | 128,06 | L/PSY,SEX,URN |
| 23342 | ANDROCUR-DEPOT | inj 3x3ml/300mg | SAG | D | |||
| 219 | G03XA | antigonadotrofiny a podobná léčiva | p.o. | L/GYN,END,HEM,ALG,SEX | |||
| 219.1 | G03XA01 | danazol | p.o. | 0.6 | GM | 83,68 | L/GYN,END,HEM, ALG,SEX |
| 67525 | ANARGIL 100MG | cps 100x100mg | MOE | CY | |||
| 67526 | ANARGIL 100MG | cps 200x100mg | MOE | CY | |||
| 67527 | ANARGIL 100MG | cps 500x100mg | MOE | CY | |||
| 67528 | ANARGIL 200MG | cps 100x200mg | MOE | CY | |||
| 67529 | ANARGIL 200MG | cps 200x200mg | MOE | CY | |||
| 67530 | ANARGIL 200MG | cps 500x200mg | MOE | CY | |||
| 219.2 | G03XA02 | gestrinon | p.o. | 0.7 | MG | 47,36 | L/GYN,END,HEM, ALG,SEX |
| 219.3 | G03XC01 | raloxifen | p.o. | 60 | MG | 39,40 | P |
| 84722 | EVISTA | tbl obd 28x60mg | LIL | GB |
Raaloxifen: léčbu ordinuje internista, endokrinolog, revmatolog a ortoped: Postmenopauzální osteoporoza žen dokumentovaná denzitometricky (méně než -2,5 SD) nebo u žen s osteoporotickou zlomeninou, u kterých selhala hormonální substituční léčba(HRT) nebo z objektivních důvodů nelze použít HRT. Léčba je dlouhodobá, trvá nejméně jeden rok. Terapie delší než jeden rok pouze u pacientek s prokazatelnou zástavou úbytku kostní hmoty
| 220 | G04AB | chinolonová chemoterapeutika močových infekcí | p.o. | ||||
|---|---|---|---|---|---|---|---|
| 220.1 | G04AB01 | kyselina nalidixová | p.o. | 4 | GM | 8,55 | |
| 220.2 | G04AB03 | kyselina pipemidová | p.o. | 0.8 | GM | 19,55 | |
| 221 | G04AC | nitrofuranová chemoterapeutika močových infekcí | p.o. | ||||
| 221.1 | G04AC02 | nifurtinol | p.o. | 0.16 | GM | 2,58 | |
| 222 | G04BC | rozpouštědla močových kamenů | p.o. | ||||
| 222.1 | G04BC | rozpouštědla močových kamenů (ve formě prášku) | p.o. | 10 | GM | 5,97 | |
| 02150 | ALKALIT | gra 1x200gm | IHO | CZ | |||
| 222.2 | G04BC | rozpouštědla močových kamenů (ve formě eff. tablet) | p.o. | 4 | DF | 5,97 | |
| 223 | G04BD | spasmolytika močových cest | p.o. | L/URN,GYN,SEX, GER | |||
| 223.1 | G04BD02 | flavoxat | p.o. | 0.8 | GM | 13,24 | L/URN,GYN,SEX GER |
| 223.2 | G04BD04 | oxybutynin | p.o. | 15 | MG | 13,24 | L/URN,GYN,SEX GER |
| 66791 | DITROPAN | tbl 30x5mg | MDD | F | |||
| 59104 | UROXAL 5MG | tbl 60x5mg | FFR | F | |||
| 223.3 | G04BD06 | propiverin (do 5 mg v jedné tabletě včetně) | p.o. | 15 | MG | 12,05 | L/URN,GYN,SEX PDD, GER |
| 66819 | MICTONETTEN | drg 50x5mg | APG | D | |||
| 92255 | MICTONETTEN | drg 30x5mg | APG | D | |||
| 66820 | MICTONETTEN | drg 100x5mg | APG | D | |||
| 223.4 | G04BD06 | propiverin (nad 5 mg v jedné tabletě) | p.o. | 15 | MG | 5,40 | L/URN,GYN,SEX,GER |
| 92254 | MICTONORM | drg 30x15mg | APG | D | |||
| 66817 | MICTONORM | drg 50x15mg | APG | D | |||
| 66818 | MICTONORM | drg 100x15mg | APG | D | |||
| 223.5 | G04BD07 | tolterodin | p.o. | 4 | MG | 30,00 | L/URN,GYN,SEX,GER |
| 224 | G04BX | jiná urologika, k léčbě benigní hyperplasie prostaty | p.o. | L/URN | |||
| 224.1 | G04CA01 | alfuzosin | p.o. | 7.5 | MG | 21,50 | L/URN |
| 224.2 | G04CA01 | alfuzosin (SR nebo retardované formy) | p.o. | 10 | MG | 21,50 | L/URN |
| 224.3 | G04CA02 | tamsulosin | p.o. | 0.4 | MG | 21,50 | L/URN |
| 224.4 | G04CA03 | terazosin | p.o. | 5 | MG | 18,10 | L/URN |
| 224.5 | G04CB01 | finasterid | p.o. | 5 | MG | 21,50 | L/URN |
| 65988 | PENESTER | tbl obd 30x5mg | LEX | CZ | |||
| 224.6 | G04CX01 | extrakt Pyg. africanum | p.o. | 2 | DF | 17,50 | L/URN |
| 42212 | TADENAN 50MG | cps 30 | DEB | F | |||
| 224.7 | G04CX02 | extrakt Serenoa repens včetně kombinací | p.o. | 2 | DF | 17,50 | L/URN |
| 57898 | SPALDA SABAL 160MG | cps 200x160mg | KKA | D | |||
| 57897 | SPALDA SABAL 160MG | cps 120x160mg | KKA | D | |||
| 57893 | SPALDA SABAL 320MG | cps 60x320mg | KKA | D | |||
| 57896 | SPALDA SABAL 160MG | cps 60x160mg | KKA | D | |||
| 57894 | SPALDA SABAL 320MG | cps 120x320mg | KKA | D | |||
| 57895 | SPALDA SABAL 320MG | cps 200x320mg | KKA | D | |||
| 07428 | PROSTAKAN MONO | cps 120x160mg | SCE | D | |||
| 224.8 | G04CX03 | mepartricin | p.o. | 150 | KU | 21,50 | L/URN |
| 55999 | IPERTROFAN 40 | tbl ent 30x40mg | SPA | I | |||
| 225 | H01A | hormony předního laloku hypofýzy | parent. | ||||
| 225.1 | H01AA02 | tetrakosaktid (nedepotní lékové formy) | parent. | 0.25 | MG | 59,93 | L/END |
| 225.2 | H01AC01 | somatropin | parent. | 2 | U | 765,20 | L/J5 |
| 56362 | ZOMACTON 12 | inj sic 5x12ut+solv | FEI | D | |||
| 96132 | NORDITROPIN PENSET 12UT | inj sic 1x12ut+solv | NOO | DK | |||
| 96133 | NORDITROPIN PENSET 24UT | inj sic 1x24ut+solv | NOO | DK | |||
| 56033 | NORDITROPIN12I.U. | inj sic 1x12ut+solv | NOO | DK | |||
| 61227 | SAIZEN 10 | inj sic 1x10ut+5ml | SRO | CH | |||
| 226 | H01BA | vasopresin a jeho deriváty | parent. | H | |||
| 226.1 | H01BA02 | desmopresin | parent. | 4 | RG | 82,41 | O |
| 04070 | ADIURETIN | inj 5x1ml/4rg | FRL | CZ | |||
| 226.2 | H01BA04 | terlipresin (do 0,5 mg včetně v jedné ampuli) | parent. | 1 | MG | 301,88 | H |
| 44356 | REMESTYP 0.5 | inj 5x5ml/0.5mg | FRL | CZ | |||
| 03648 | REMESTYP 0.2 | inj 5x2ml/0.2mg | FRL | CZ | |||
| 226.3 | H01BA05 | ornipresin | parent. | 5 | U | 27,57 | H |
| 226.4 | H01BA04 | terlipresin (nad 0,5 mg v jedné ampuli) | parent. | 1 | MG | 245,27 | H |
| 227 | H01BA | vasopresin a jeho deriváty | lok. | ||||
| 227.1 | H01BA02 | desmopresin (nosní kapky) | lok. | 25 | RG | 21,86 | |
| 02634 | ADIURETIN SD | gtt nas 1x5ml/0.5mg | FRL | CZ | |||
| 227.2 | H01BA02 | desmopresin (nosní spray) | lok. | 25 | RG | 21,86 | |
| 227.3 | H01BA02 | desmopresin (pevné lékové formy) | p.o. | 400 | RG | 21,86 | |
| 228 | H01BB | oxytocin a jeho deriváty | parent. | H | |||
| 228.1 | H01BB02 | oxytocin (do 2 U v jedné ampuli včetně) | parent. | 15 | U | 46,95 | H |
| 00543 | OXYTOCIN FERRING-LECIVA | inj 5x2ml/2ut | FRL | CZ | |||
| 228.2 | H01BB02 | oxytocin (nad 2 U v jedné ampuli) | parent. | 15 | U | 21,00 | H |
| 00544 | OXYTOCIN FERRING-LECIVA | inj 5x1ml/5ut | FRL | CZ | |||
| 229 | H01CA | hormon uvolňující gonadotrofin | lok. | Z | |||
| 229.1 | H01CA01 | gonadorelin (nasálně) | lok. | 1.2 | MG | 203,34 | Z |
| 229.2 | H01CA02 | nafarelin do 4 ml včetně v jednom balení (nasálně) | lok. | 0,4 | MG | 147,61 | Z |
| 45481 | SYNAREL | spr nas 1x4ml | SEA | POR | |||
| 229.3 | H01CA02 | nafarelin nad 4 ml v jednom balení (nasálně) | lok. | 0,4 | MG | 116,04 | Z |
| 83795 | SYNAREL | spr nas 1x8ml | SEA | POR | |||
| 229.4 | H01CC01 | ganirelix (antagonista gonadotropin releasing hormonu ) | parent. | 0,25 | MG | 1600,00 | Z |
| 05979 | ORGALUTRAN 0.25MG/0.5ML INJ.ROZ | inj sol 5x0.5ml | ORG | NL | |||
| 05980 | ORGALUTRAN 0.25MG/0.5ML INJ.ROZ | inj sol 1x0.5ml | ORG | NL | |||
| 05981 | ORGALUTRAN 0.25MG/0.5ML INJ.ROZ | inj sol 1x0.5ml | ORG | IRL | |||
| 05982 | ORGALUTRAN 0.25MG/0.5ML INJ.ROZ | inj sol 5x0.5ml | ORG | IRL | |||
| 230 | H01CB | somatostatin a jeho deriváty | parent. | X | |||
| 230.1 | H01CB01 | somatostatin | parent. | 6 | MG | 7941,40 | X |
| 92109 | SOMATOSTATIN | inj sic 1x250rg+1ml | UCB | B | |||
| 66824 | SOMATOSTATIN | inj sic 1x3mg+solv. | UCB | B | |||
| 97824 | STILAMIN | inj sic 1x3mg | SRO | CH | |||
| 230.2 | H01CB02 | oktreotid | parent. | 1 | MG | 5022,50 | X |
| 93864 | SANDOSTATIN | inj 5x1 ml/0.05mg | SAN | CH | |||
| 93865 | SANDOSTATIN | inj 5x1 ml/0.1 mg | SAN | CH | |||
| 93866 | SANDOSTATIN | inj 5x1 ml/0.5mg | SAN | CH | |||
| 93867 | SANDOSTATIN | inj 1x5ml/1mg-lahv. | SAN | CH | |||
| 230.3 | H01CB02 | oktreotid s podáváním 1x měsíčně s obsahem 10 MG | parent. | 0,35 7 | MG | 1434,00 | X |
| 230.4 | H01CB02 | oktreotid s podáváním 1x měsíčně s obsahem 20 MG | parent. | 0,71 4 | MG | 1912,00 | X |
| 230.5 | H01CB02 | oktreotid s podáváním 1x měsíčně s obsahem 30 MG | parent. | 1,07 2 | MG | 2390,00 | X |
| 230.6 | H01CB03 | lantreotid | parent. | 2,14 | MG | 1840,57 | X |
| 84701 | SOMATULINE P.R. | inj sic 1x30mg+solv | IPE | F | |||
| 231 | H02AA | mineralokortikoidy | p.o. | ||||
| 231.1 | H02AA02 | fludrokortison | p.o. | 0.1 | MG | 4,79 | |
| 23865 | FLUDROCORTISON | tbl 100x0.1 mg | SQH | D | |||
| 232 | H02AB | glukokortikoidy | p.o. | ||||
| 232.1 | H02AB01 | betamethason | p.o. | 1.5 | MG | 3,42 | |
| 232.2 | H02AB02 | dexamethason (4 mg v jedné tabletě a více) | p.o. | 1.5 | MG | 10,22 | |
| 83994 | FORTECORTIN 4 | tbl 20x4mg | MEC | D | |||
| 232.3 | H02AB02 | dexamethason (méně než 4 mg v jedné tabletě) | p.o. | 1.5 | MG | 3,42 | |
| 86698 | DEXAMETHAZON LECIVA | tbl 20x0.5mg-blistr | LEX | CZ | |||
| 70508 | DEXONA | tbl 100x0.5mg | CAD | IND | |||
| 232.4 | H02AB04 | methylprednisolon (do 8 mg v jedné tabletě včetně) | p.o. | 7.5 | MG | 3,42 | |
| 232.5 | H02AB04 | methylprednisolon (nad 8 mg v jedné tabletě) | p.o. | 7.5 | MG | 5,43 | |
| 86606 | MEDROL | tbl 50x16mg(blistr) | UPJ | B | |||
| 93617 | MEDROL | tbl 50x16mg(lekov.) | UPJ | B | |||
| 232.6 | H02AB07 | Prednison | p.o. | 10 | MG | 2,62 | |
| 02963 | PREDNISON 20 LECIVA | tbl 20x20mg(blistr) | LEX | CZ | |||
| 00269 | PREDNISON 5 LECIVA | tbl 20x5mg | LEX | CZ | |||
| 232.7 | H02AB08 | triamcinolon | p.o. | 7.5 | MG | 2,74 | |
| 00332 | TRIAMCINOLON LECIVA | tbl 20x4mg | LEX | CZ | |||
| 232.8 | H02AB09 | hydrokortison | p.o. | 30 | MG | 7,33 | |
| 76205 | HYDROCORTISON 10MG JENAPHARM | tbl 20x10mg | VJP | D | |||
| 232.9 | H02AB10 | kortison | p.o. | 37.5 | MG | 5,72 | |
| 232.10 | H02AB07 | prednison (do 10 mg včetně) | p.rect. | 10 | MG | 17,30 | |
| 232.11 | H02AB07 | prednison (nad 30 mg) | p.rect. | 10 | MG | 4,59 | |
| 232.12 | H02AB07 | prednison (nad 10 do 30 mg včetně) | p.rect. | 10 | MG | 8,16 | |
| 233 | H02AB | glukokortikoidy | parent. | O | |||
| 233.1 | H02AB | mazipredon | parent. | 30 | MG | 17,79 | O |
| 02125 | DEPERSOLON | inj 3x1ml/30mg | GED | H | |||
| 233.2 | H02AB01 | betamethason (depotní lékové formy) | parent. | 0.4 | MG | 3,69 | O |
| 89870 | DIPROPHOS | inj 1x1ml | SCH | B | |||
| 78257 | DIPROPHOS | inj 5x1ml | SCH | F | |||
| 233.3 | H02AB02 | dexamethason (40 mg v jedné ampuli) | parent. | 1.5 | MG | 24,87 | O |
| 99479 | FORTECORTIN MONO 40(AMPULE) | inj 1x5ml/40mg | MEC | D | |||
| 233.4 | H02AB02 | dexamethason (do 8 mg v jedné ampuli včetně) | parent. | 1.5 | MG | 2,54 | O |
| 84090 | DEXAMED | inj 10x2ml/8mg | MOE | CY | |||
| 96108 | DEXONA | inj 6x2ml 4mg/ml | CAD | IND | |||
| 96109 | DEXONA | inj 8x6x2ml | CAD | IND | |||
| 01673 | DEXAMED | inj 100x2ml/8mg | MOE | CY | |||
| 233.5 | H02AB04 | methylprednisolon (do 80 mg v jedné ampuli včetně) | parent. | 20 | MG | 35,70 | O |
| 09709 | SOLU-MEDROL | inj sic 1x40mg+1ml | UPJ | B | |||
| 233.6 | H02AB04 | methylprednisolon (nad 500 mg v jedné ampuli) | parent. | 20 | MG | 15,25 | O |
| 233.7 | H02AB04 | methylprednisolon (nad 80 do 500 mg v jedné ampuli včetně) | parent. | 20 | MG | 22,11 | O |
| 09711 | SOLU-MEDROL | inj sic 1x500mg+8ml | UPJ | B | |||
| 233.8 | H02AB06 | prednisolon (do 50 mg v jedné ampuli včetně) | parent. | 10 | MG | 17,84 | O |
| 09705 | SOLU-DECORTIN H 50 | inj sic 1x50mg+1ml | MEC | D | |||
| 233.9 | H02AB06 | prednisolon (nad 50 mg v jedné ampuli) | parent. | 10 | MG | 12,51 | O |
| 09707 | SOLU-DECORTIN H 250 | inj sic 1x250mg+2ml | MEC | D | |||
| 233.10 | H02AB08 | triamcinolon | parent. | 7.5 | MG | 13,64 | O |
| 08006 | KENALOG 10 | inj 1x5ml/50mg | LEX | CZ | |||
| 02126 | KENALOG 40 | inj 1x5ml/200mg | LEX | CZ | |||
| 233.11 | H02AB09 | hydrokortison | parent. | 30 | MG | 11,19 | O |
| 06199 | SOLU-CORTEF | inj sic 25x100mg | UPJ | B | |||
| 00484 | HYDROCORTISON SOLUBILE VUAB | inj 1x100mg | VUA | CZ | |||
| 234 | H03AA | hormony štítné žlázy | p.o. | ||||
| 234.1 | H03AA | hormony štítné žlázy | p.o. | 1 | DF | 2,15 | |
| 61161 | JODTHYROX | tbl 100 | MEC | D | |||
| 61160 | JODTHYROX | tbl 50 | MEC | D | |||
| 234.2 | H03AA01 | levothyroxin sodný (do 50 RG v 1 tabletě včetně) | p.o. | 0.15 | MG | 1,96 | |
| 47141 | LETROX 50 | tbl 100x50rg | BCE | D | |||
| 69189 | EUTHYROX 50 | tbl 100x50rg | MEC | D | |||
| 234.3 | H03AA01 | levothyroxin sodný (nad 50 RG do 100 RG včetně v 1 tabletě) | p.o. | 0.15 | MG | 1,37 | |
| 47144 | LETROX 100 | tbl 100x100rg | BCE | D | |||
| 97186 | EUTHYROX 100 | tbl 100x100rg | MEC | D | |||
| 234.4 | H03AA01 | levothyroxin sodný (nad 100 RG v 1 tabletě) | p.o. | 0.15 | MG | 1,12 | |
| 47133 | LETROX 150 | tbl 100x150rg | BCE | D | |||
| 234.5 | H03AA02 | liothyronin sodný | p.o. | 0.06 | MG | 4,40 | |
| 09805 | TERTROXIN | tbl 100x0.02mg | GLA | GB | |||
| 234.6 | H03AA03 | kombinace levothyroxinu a liothyroninu | p.o. | 1 | DF | 1,81 | |
| 03875 | THYREOTOM | tbl 60x50rg | BCE | D | |||
| 234.7 | H03CA | jódová terapie | p.o. | 200 | RG | 1,81 | |
| 61158 | JODID 100 | tbl 100 | MEC | D | |||
| 61159 | JODID 200 | tbl 100 | MEC | D | |||
| 235 | H03B | thyreostatika | p.o. | ||||
| 235.1 | H03BA02 | propylthiouracil | p.o. | 0.1 | GM | 7,76 | |
| 09577 | PROPYCIL 50 | tbl 100x50mg | KCH | D | |||
| 09576 | PROPYCIL 50 | tbl 20x50mg | SVP | D | |||
| 235.2 | H03BB01 | karbimazol | p.o. | 15 | MG | 3,11 | |
| 00066 | CARBIMAZOL SLOVAKOFARMA | tbl 100x5mg | SLO | SK | |||
| 235.3 | H03BB02 | thiamazol | p.o. | 10 | MG | 2,83 | |
| 235.4 | H03BC01 | perchlorát draselný | p.o. | 0.2 | GM | 1,66 | |
| 236 | H03B | thyreostatika | parent. | H | |||
| 236.1 | H03BB02 | thiamazol | parent. | 10 | MG | 4,50 | H |
| 237 | H04AA | glukagon a jeho deriváty | parent. | L/DIA | |||
| 237.1 | H04AA01 | glukagon | parent. | 1 | MG | 404,62 | L/DIA |
| 237.2 | H04AA01 | glukagon (ve formě hypokit) | parent. | 1 | MG | 811,39 | L/DIA |
| 83741 | GLUCAGEN 1MG HYPOKIT | inj sic 1mg+strik. | DK | ||||
| 238 | H05BA | kalcitonin | inhal. | L/INT,GYN,ORT,END | |||
| 238.1 | H05BA01 | kalcitonin (lososí, do 100 U včetně v jedné dávce) | inhal. | 200 | U | 104,13 | L/INT,ORT,END |
| 64662 | TONOCALCIN 100I.U.NOSNÍ SPREJ | spr nas 1x3.5ml | MCI | CZ | |||
| 238.2 | H05BA01 | kalcitonin (lososí, nad 100 U v jedné dávce) | inhal. | 200 | U | 83,00 | L/INT,ORT,END |
| 10146 | TONOCALCIN 200 I.U.NOSNÍ SPREJ | spr nas 1x3.5ml | MCI | CZ | |||
| 239 | H05BA | kalcitonin | parent. | L/INT,GYN,ORT,END | |||
| 239.1 | H05BA01 | kalcitonin (lososí) | parent. | 100 | U | 118,09 | L/INT,ORT,END |
| 89017 | UCECAL 50 I.U. | inj 5x1ml/50ut | UCB | B | |||
| 239.2 | H05BA03 | kalcitonin (lidský, do 50 U v jedné ampuli včetně) | parent. | 100 | U | 125,37 | L/INT,ORT, END |
| 239.3 | H05BA03 | kalcitonin (lidský, nad 50 U v jedné ampuli) | parent. | 100 | U | 157,39 | L/INT,ORT, END |
| 240 | J01AA | tetracyklinová antibiotika | p.o. | ||||
| 240.1 | J01AA02 | doxycyklin | p.o. | 0.1 | GM | 4,01 | |
| 90986 | DEOXYMYKOIN | tbl 10x100mg | LEX | CZ | |||
| 12735 | DOXYHEXAL 200 TABS | tbl 10x200mg | HEX | D | |||
| 12736 | DOXYHEXAL 200 TABS | tbl 20x200mg | HEX | D | |||
| 12741 | DOXYHEXAL TABS | tbl 10x100mg | HEX | D | |||
| 12742 | DOXYHEXAL TABS | tbl 20x100mg | HEX | D | |||
| 240.2 | J01AA04 | lymecyklin | p.o. | 0.6 | GM | 4,01 | |
| 240.3 | J01AA06 | oxytetracyklin | p.o. | 1 | GM | 4,01 | |
| 240.4 | J01AA07 | tetracyklin | p.o. | 1 | GM | 4,01 | |
| 240.5 | J01AA08 | minocyklin | p.o. | 0.2 | GM | 4,01 | |
| 240.6 | J01AA52 | doxycyklin v kombinaci s ambroxolem | p.o. | 1 | DF | 7,00 | |
| 241 | J01AA | tetracyklinová antibiotika | parent. | K | |||
| 241.1 | J01AA02 | doxycyklin | parent. | 0.1 | GM | 94,63 | K |
| 12705 | DOXYHEXAL SF | inj 2x5ml/100mg | HEX | D | |||
| 12706 | DOXYHEXAL SF | inj 5x5ml/100mg | HEX | D | |||
| 241.2 | J01AA09 | rolitetracyklin | parent. | 0.35 | GM | 94,63 | K |
| 242 | J01BA | amfenikolová antibiotika | p.o. | ||||
| 242.1 | J01BA01 | chloramfenikol | p.o. | 3 | GM | 24,73 | |
| 71951 | CHLORAMPHENICOL LECIVA | cps 30x250mg | LEX | CZ | |||
| 243 | J01BA | amfenikolová antibiotika | parent. | K | |||
| 243.1 | J01BA01 | chloramfenikol | parent. | 3 | GM | 255,63 | K |
| 97390 | CHLORAMPHENICOL SOLUBILE VUAB | inj sic 1x1gm | VUA | CZ | |||
| 243.2 | J01BA02 | thiamphenikol | parent. | 1.5 | GM | 176,31 | K |
| 244 | J01CA | aminopenicilinová antibiotika | p.o. | ||||
| 244.1 | J01CA01 | ampicilin (pevné lékové formy) | p.o. | 2 | GM | 14,13 | |
| 244.2 | J01CA01 | ampicilin (tekuté lékové formy) | p.o. | 2 | GM | 17,20 | |
| 244.3 | J01CA04 | amoxicilin (pevné lékové formy) do 0,5 GM v 1tabletě včetně | p.o. | 1 | GM | 10,12 | |
| 66368 | OSPAMOX 500MG | tbl obd 12x500mg | BCA | A | |||
| 66828 | AMOCLEN 250 | cps 30x250mg | LEX | CZ | |||
| 66829 | AMOCLEN 500 | cps 30x500mg | LEX | CZ | |||
| 53681 | AMOXICILLIN 250-SLOVAKOFARMA | cps 30x250mg | SLO | SK | |||
| 53682 | AMOXICILLIN 500-SLOVAKOFARMA | cps 30x500mg | SLO | SK | |||
| 244.4 | J01CA04 | amoxicilin (pevné lékové formy) nad 0,5 GM v 1tabletě | p.o. | 1 | GM | 9,06 | |
| 66370 | OSPAMOX 1000MG | tbl obd 12x1000mg | BCA | A | |||
| 66369 | OSPAMOX 750MG | tbl obd 12x750mg | BCA | A | |||
| 44343 | AMOXIHEXAL 1000 | tbl obd 20x1000mg | HCC | D | |||
| 44333 | AMOXIHEXAL 750 TABS | tbl sol 12x750mg | HHC | D | |||
| 44334 | AMOXIHEXAL 750 TABS | tbl sol 24x750mg | HHC | D | |||
| 44335 | AMOXIHEXAL 1000 TABS | tbl sol 12x1000mg | HHC | D | |||
| 44336 | AMOXIHEXAL 1000 TABS | tbl sol 24x1000mg | HHC | D | |||
| 244.5 | J01CA04 | amoxicilin (tekuté lékové formy do 0,5 GM včetně v 5 mililitrech) | p.o. | 1 | GM | 13,05 | |
| 62050 | DUOMOX 500 | tbl 20x500mg | YEU | NL | |||
| 66366 | OSPAMOX 250MG/5ML | gra sus 1x60ml | BCA | A | |||
| 66367 | OSPAMOX 375MG/5ML | gra sus 1x60ml | BCA | A | |||
| 84510 | AMOCLEN 250 | sir sic 1x5gm/100ml | LEX | CZ | |||
| 244.6 | J01CA04 | amoxicilin (tekuté lékové formy nad 0,5 GM v 5 mililitrech) | p.o. | 1 | GM | 10,00 | |
| 244.7 | J01CA06 | bakampicilin | p.o. | 1.2 | GM | 16,62 | |
| 245 | J01CA | aminopenicilinová antibiotika | parent. | K | |||
| 245.1 | J01CA01 | ampicilin | parent. | 2 | GM | 27,08 | K |
| 60248 | PENTREXYL | inj sic 50x250mg | BMS | I | |||
| 246 | J01CA | acylureidová antibiotika | parent. | U/ATB | |||
| 246.1 | J01CA09 | azlocilin | parent. | 12 | GM | 637,48 | U/ATB |
| 04035 | SECUROPEN | inj sic 5x2gm+20ml | BAY | D | |||
| 46974 | SECUROPEN 2GM | inj sic 5x2gm | BAY | D | |||
| 97002 | SECUROPEN | inf 5x5gm | BAY | D | |||
| 246.2 | J01CA12 | piperacilin | parent. | 14 | GM | 1297,98 | U/ATB |
| 12336 | PIPRAKS | inj sic 1x2gm+10ml | ECZ | TR | |||
| 246.3 | J01CA13 | tikarcilin | parent. | 15 | GM | 1980,92 | U/ATB |
| 247 | J01CE | na beta-laktamázu citlivé peniciliny | p.o | ||||
| 247.1 | J01CE02 | fenoxymethylpenicilin (nad 900 KU v jedné tabletě) | p.o. | 2 | GM | 19,65 | |
| 45997 | OSPEN 1000 | tbl obd 30x1000ku | BCA | A | |||
| 45998 | OSPEN 1500 | tbl obd 30x1500ku | BCA | A | |||
| 49513 | PENBENE | tbl obd 30x1mu | MCK | D | |||
| 64936 | PENCID 1500 | tbl obd 20x1.5mu | LEX | CZ | |||
| 64937 | PENCID 1000 | tbl obd 20x1mu | LEX | CZ | |||
| 65356 | PENBENE | tbl obd 12x1mu | MCK | D | |||
| 66359 | OSPEN 1000 | tbl obd 12x1000ku | BCA | A | |||
| 66360 | OSPEN 1500 | tbl obd 12x1500ku | BCA | A | |||
| 247.2 | J01CE02 | fenoxymethylpenicilin (méně než 500 KU v jedné tabletě) | p.o. | 2 | GM | 21,02 | |
| 92805 | V-PENICILIN 250MG SLOVAKOFARMA | tbl 30x250mg-blistr | SLO | SK | |||
| 247.3 | J01CE02 | fenoxymethylpenicilin (od 500 KU včetně do 900 KU včetně v jedné tabletě) | p.o. | 2 | GM | 19,11 | |
| 92806 | V-PENICILIN 500MG SLOVAKOFARMA | tbl 30x500mg-blistr | SLO | SK | |||
| 247.4 | J01CE06 | penamecilin | p.o. | 1.05 | GM | 14,52 | |
| 56442 | PENCLEN | tbl 30x350mg-blistr | SLO | SK | |||
| 247.5 | J01CE10 | benzathin fenoxymethylpenicilin | p.o. | 2 | GM | 29,43 | |
| 49549 | OSPEN 400MG | sir 1x150ml | BCA | A | |||
| 247.6 | J01CE02 | fenoxymethylpenicilin (tekuté lékové formy do 250 KU v 5 ml včetně) | p.o. | 2 | GM | 69.99 | |
| 247.7 | J01CE02 | fenoxymethylpenicilin (tekuté lékové formy nad 250 KU v 5 ml) | p.o. | 2 | GM | 26,30 | |
| 248 | J01CE | na beta-laktamázu citlivé peniciliny | parent. | K | |||
| 248.1 | J01CE01 | benzylpenicilin (do 1 MU v jedné ampuli včetně) | parent. | 3.6 | GM | 123,86 | K |
| 01093 | PENICILIN G DRASEL.SOL BIOTIKA | inj sic 10x1mu | BTA | SK | |||
| 02136 | PENICILIN G DRASEL.SOL BIOTIKA | inj sic 10x500ku | BTA | SK | |||
| 248.2 | J01CE01 | benzylpenicilin (nad 1 MU v jedné ampuli) | parent. | 3.6 | GM | 49,32 | K |
| 93405 | PENICILIN G DRASEL.SOL BIOTIKA | inj sic 10x5mu | BTA | SK | |||
| 248.3 | J01CE08 | benzathin benzylpenicilin (do 0,6 MU v jedné ampuli včetně) | parent. | 2 | MU | 70,63 | K |
| 248.4 | J01CE08 | benzathin benzylpenicilin (nad 0,6 MU v jedné ampuli) | parent. | 2 | MU | 32,94 | K |
| 50160 | RETARPEN 2.4 M.U.I. | inj sic 50x2.4mu | BCW | A | |||
| 248.5 | J01CE09 | prokain penicilin (do 0,6 MU v jedné dávce včetně) | parent. | 2 | MU | 79,58 | K |
| 248.6 | J01CE09 | prokain penicilin (nad 0,6 MU v jedné dávce) | parent. | 2 | MU | 39,05 | K |
| 01102 | PROKAIN PENICILIN G BIOTIKA | inj 10x1.5mu | BTA | SK | |||
| 248.7 | J01CE30 | kombinace | parent. | 0.5 | DF | 10,36 | K |
| 02723 | PENDEPON COMPOSITUM | inj 10x1.5mu | BTA | SK | |||
| 249 | J01CF | vůči beta-laktamáze stabilní peniciliny | p.o. | ||||
| 249.1 | J01CF02 | cloxacilin (pevné lékové formy) | p.o. | 2 | GM | 28,74 | |
| 249.2 | J01CF02 | cloxacilin (tekuté lékové formy) | p.o. | 2 | GM | 39,98 | |
| 249.3 | J01CF04 | oxacilin (pevné lékové formy) | p.o. | 2 | GM | 28,74 | |
| 02677 | OXACILIN 250 LECIVA | cps 60x250mg | LEX | CZ | |||
| 76201 | PROSTAPHLIN 500MG | cps 40x500mg | BMS | I | |||
| 249.4 | J01CF04 | oxacilin (tekuté lékové formy) | p.o. | 2 | GM | 39,98 | |
| 250 | J01CF | vůči beta-laktamáze stabilní peniciliny | parent. | K | |||
| 250.1 | J01CF04 | oxacilin | parent. | 2 | GM | 98,74 | K |
| 92359 | PROSTAPHLIN 1000MG | inj sic 1x1000mg | BMS | I | |||
| 251 | J01CR | kombinace inhibitoru beta-laktamázy s peniciliny | p.o. | ||||
| 251.1 | J01CR04 | sultamicilin (pevné lékové formy) | p.o. | 1.5 | GM | 83,58 | |
| 251.2 | J01CR04 | sultamicilin (tekuté lékové formy) | p.o. | 1.5 | GM | 80,90 | |
| 251.3 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (pevné lékové formy, do 375 mg v 1 tabletě včetně) | p.o. | 1 | GM | 31,80 | |
| 251.4 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (pevné lékové formy, nad 375 mg do 625 mg včetně v 1 tabletě) | p.o. | 1 | GM | 28,98 | |
| 251.5 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (pevné lékové formy, nad 625 mg v 1 tabletě) | p.o. | 1 | GM | 27,18 | |
| 12494 | AUGMENTIN 1GM | tbl 14x1gm | SKB | GB | |||
| 251.6 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (tekuté lékové formy do 156 mg v 5 ml včetně) | p.o. | 1 | GM | 47,44 | |
| 53567 | CURAM 156.25MG/5ML | plv sus 1x100ml | BCA | A | |||
| 251.7 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (tekuté lékové formy, nad 156 mg v 5 ml) | p.o. | 1 | GM | 31,12 | |
| 84792 | AUGMENTIN DUO | plv sus 1x70ml | SKW | GB | |||
| 252 | J01CR | kombinace inhibitoru beta-laktamázy s peniciliny, nebo kombinace penicilinů | parent. | U/ATB | |||
| 252.1 | J01CR01 | ampicilin a enzymový inhibitor | parent. | 2 | GM | 162,17 | U/ATB |
| 252.2 | J01CR02 | amoxicilin a inhibitor beta-laktamázy | parent. | 1 | GM | 109,88 | U/ATB |
| 97660 | AUGMENTIN 1,2GM | inj sic 5x1.2gm | LEX | CZ | |||
| 252.3 | J01CR03 | tikarcilin a inhibitor beta-laktamázy | parent. | 15 | GM | 1820,84 | U/ATB |
| 252.4 | J01CR05 | piperacilin a inhibitor beta-laktamázy | parent. | 14 | GM | 1980,92 | U/ATB |
| 252.5 | J01CR50 | kombinace penicilinů | parent. | 3 | DF | 71,80 | U |
| 252.6 | J01DA | cefoperazon a inhibitor beta-laktamázy | parent. | 2 | GM | 397,00 | U/ATB |
| 253 | J01DA | cefalosporinová antibiotika | p.o. | ||||
| 253.1 | J01DA01 | cefalexin (pevné lékové formy) | p.o. | 2 | GM | 38,13 | |
| 66357 | OSPEXIN 1000MG | tbl obd 12x1000mg | BCA | A | |||
| 06158 | ORACEF | cps 16x500mg | KRK | SLO | |||
| 66356 | OSPEXIN 500MG | tbl obd 12x500mg | BCA | A | |||
| 253.2 | J01DA01 | cefalexin (tekuté lékové formy) | p.o. | 2 | GM | 44,33 | |
| 66354 | OSPEXIN 250MG/5ML | gra sus 1x60ml | BCA | A | |||
| 66355 | OSPEXIN 375MG/5ML | gra sus 1x60ml | BCA | A | |||
| 253.3 | J01DA06 | cefuroxim axetil (pevné lékové formy) | p.o. | 1 | GM | 92,35 | |
| 76366 | ZINNAT | tbl fc 10x125mg | GLA | I | |||
| 76367 | ZINNAT | tbl fc 10x250mg | GLA | I | |||
| 76368 | ZINNAT | tbl fc 10x500mg | GLA | I | |||
| 253.4 | J01DA06 | cefuroxim axetil (tekuté lékové formy) | p.o. | 1 | GM | 141,75 | |
| 96016 | ZINNAT | gra sus 1x50ml | GLA | GB | |||
| 253.5 | J01DA08 | cefaklor (pevné lékové formy do 375 mg v 1 tabletě včetně) | p.o. | 1.5 | GM | 72,88 | |
| 53153 | VERCEF 250 MG | cps 7x3 (blistr) | RXY | IND | |||
| 69474 | CECLOR RETARD 375MG | tbl obd 10x375mg | LIL | I | |||
| 253.6 | J01DA08 | cefaklor (pevné lékové formy nad 375 mg v 1 tabletě) | p.o. | 1.5 | GM | 66,03 | |
| 53157 | VERCEF 500 MG | cps 7x3 (blistr) | RXY | IND | |||
| 69475 | CECLOR RETARD 750MG | tbl obd 10x750mg | LIL | I | |||
| 45193 | CEC 500 | tbl obd 10x500mg | SFS | D | |||
| 45194 | CEC 500 | tbl obd 20x500mg | SFS | D | |||
| 253.7 | J01DA08 | cefaklor (tekuté lékové formy, do 125 mg/5 ml včetně) | p.o. | 1.5 | GM | 103,11 | |
| 45195 | CEC SIRUP | plv sus 100ml/2.5gm | SFS | D | |||
| 253.8 | J01DA08 | cefaklor (tekuté lékové formy, nad 125 mg/5 ml) | p.o. | 1.5 | GM | 86,27 | |
| 53152 | VERCEF250 MG/5ML | plv sus 1x100 ml | RXY | IND | |||
| 45196 | CEC FORTE SIRUP | plv sus 100ml/5gm | SFS | D | |||
| 253.9 | J01DA09 | cefadroxil (pevné lékové formy) | p.o. | 2 | GM | 44,00 | |
| 44802 | BIODROXIL | tbl obd 12x1000mg | BCA | A | |||
| 44799 | BIODROXIL | cps 12x500mg | BCA | A | |||
| 46752 | CEFADROX TABS | tbl sol 10x1000mg | SFS | D | |||
| 46753 | CEFADROX TABS | tbl sol 20x1000mg | SFS | D | |||
| 253.10 | J01DA09 | cefadroxil (tekuté lékové formy) | p.o. | 2 | GM | 68,00 | |
| 44807 | BIODROXIL 250MG/5ML | plv sus 1x60ml/3gm | BCA | A | |||
| 253.11 | J01DA23 | cefixim | p.o. | 0.4 | GM | 107,35 | ATB |
| 253.12 | J01DA26 | cefetamet | p.o. | 1 | GM | 107,53 | ATB |
| 253.13 | J01DA33 | cefpodoxim | p.o. | 0.4 | GM | 92,35 | ATB |
| 253.14 | J01DA39 | ceftibuten | p.o. | 0.4 | GM | 92,35 | ATB |
| 253.15 | J01DA41 | cefprozil (pevné lékové formy) | p.o. | 1 | GM | 92,35 | |
| 253.16 | J01DA41 | cefprozil (tekuté lékové formy) | p.o. | 1 | GM | 141,75 | |
| 254 | J01DA | cefalosporinová antibiotika | parent. | U/ATB P |
Léčbu ceftriaxonem v ambulantní péči ordinuje neurolog, infekcionista, dermatolog, pediatr nebo revmatolog:
- a) inciální léčba bakteriální meningitidy u dětí mladších 18 let,
- b) léčba Lymské boreliózy II. a III. stádium (doložené laboratorním vyšetřením),
- c) léčba nekomplikované akutní kapavky (jednorázová nitrosvalová aplikace 250 mg ceftriaxonu).
| 254.1 | J01DA03 | cefalotin | parent. | 4 | GM | 188,18 | U |
|---|---|---|---|---|---|---|---|
| 85512 | CEFALOTIN BIOTIKA | inj sic 50x1gm | BTA | SK | |||
| 254.2 | J01DA04 | cefazolin | parent. | 3 | GM | 162,06 | U |
| 02205 | CEFAZOLINE PANPHARMA | inj sic 25x1gm | LPA | F | |||
| 58092 | CEFAZOLIN BIOCHEMIE 1GM | inj sic 10x1gm | BCA | A | |||
| 83111 | ORIZOLIN | inj sic 1x1000mg | CAD | IND | |||
| 84018 | CEFAZOLINE PANPHARMA | inj sic 50x1gm | LPA | F | |||
| 85510 | VULMIZOLIN | inj sic 50x1gm | BTA | SK | |||
| 91148 | VULMIZOLIN | inj sic 10x1gm | BTA | SK | |||
| 254.3 | J01DA05 | cefoxitin | parent. | 6 | GM | 937,79 | U/ATB |
| 254.4 | J01DA06 | cefuroxim | parent. | 4 | GM | 497,69 | U/ATB |
| 76360 | ZINACEF AD INJ. | inj sic 1x1.5gm | GLA | I | |||
| 77044 | ZINACEF AD INJ. | inj sic 1x750mg | GLA | I | |||
| 83042 | ZINACEF AD INJ. | inj sic 1x750mg+6ml | GLA | I | |||
| 254.5 | J01DA07 | cefamandol | parent. | 6 | GM | 615,68 | U/ATB |
| 254.6 | J01DA10 | cefotaxim do 1 g včetně v jedné ampuli | parent. | 6 | GM | 663,29 | U/ATB |
| 94176 | CEFOTAXIME | inj 1x1gm | LEK | SLO | |||
| 254.7 | J01DA10 | cefotaxim nad 1 g v jedné ampuli | parent. | 6 | GM | 593,68 | U/ATB |
| 94177 | CEFOTAXIME | inj 1x2gm | LEK | SLO | |||
| 254.8 | J01DA11 | ceftazidim do 500 mg včetně v jedné ampuli | parent. | 6 | GM | 1736,18 | U/ATB |
| 76355 | FORTUM | inj 1x500mg | GLA | I | |||
| 83038 | FORTUM | inj 1x500mg+5ml sol | GLA | I | |||
| 254.9 | J01DA11 | ceftazidim nad 500 mg v jedné ampuli | parent. | 6 | GM | 1739,99 | U/ATB |
| 76353 | FORTUM | inj 1x1gm | GLA | I | |||
| 83039 | FORTUM | inj 1x1gm+10ml solv | GLA | I | |||
| 76354 | FORTUM | inj 1x2gm | GLA | I | |||
| 254.10 | J01DA12 | cefsulodin | parent. | 6 | GM | 615,68 | U/ATB |
| 254.11 | J01DA13 | ceftriaxon | parent. | 2 | GM | 654,12 | ambulantně: K/P ústavně: U/ATB |
| 80662 | LENDACIN 1GM | inj sic 5x1gm | LEK | SLO | |||
| 80663 | LENDACIN 250MG | inj sic 5x250mg | LEK | SLO | |||
| 87769 | ROCEPHIN ROCHE I.V. STERIL.PLV | inj sic 5x1gm+10ml | HLR | CH | |||
| 87774 | ROCEPHIN ROCHE I.M. STERIL.PLV | inj sic 5x1gm+3.5ml | HLR | CH | |||
| 254.12 | J01DA22 | ceftizoxim | parent. | 4 | GM | 615,68 | U/ATB |
| 254.13 | J01DA30 | cefapirin | parent. | 4 | GM | 194,73 | U |
| 254.14 | J01DA32 | cefoperazon | parent. | 6 | GM | 1526,24 | U/ATB |
| 254.15 | J01DA37 | cefpirom | parent. | 4 | GM | 1679,48 | U/ATB |
| 86598 | CEFROM 2GM | inj sic 1x2gm | ROU | F | |||
| 254.16 | J01DA24 | cefepim | parent. | 4 | GM | 1605,91 | U/ATB |
| 255 | J01DF | monobaktámová antibiotika | parent. | U/ATB | |||
| 255.1 | J01DF01 | aztreonam | parent. | 4 | GM | 1670,80 | U/ATB |
| 86412 | AZACTAM | inj sic 1x1gm | BMS | I | |||
| 256 | J01DH | karbapenemová antibiotika | parent | U/ATB | |||
| 256.1 | J01DH02 | meropenem | parent. | 2 | GM | 2259,20 | U/ATB |
| 83488 | MERONEM 500MG I.M. | inj sic 1x500mg+sol | ZNC | GB | |||
| 256.2 | J01DH51 | imipenem a inhibitor enzymu | parent. | 2 | GM | 2258,99 | U/ATB |
| 257 | J01EB | krátkodobě působící sulfonamidy | p.o. | ||||
| 257.1 | J01EA01 | trimethoprim (do 100 mg v jedné tabletě včetně) | p.o. | 0.4 | GM | 12,32 | |
| 89812 | TRIPRIM 100MG | tbl 10x100mg | MCK | D | |||
| 89813 | TRIPRIM 100MG | tbl 20x100mg | MCK | D | |||
| 257.2 | J01EA01 | trimethoprim (nad 100 mg v jedné tabletě) | p.o. | 0.4 | GM | 9,29 | |
| 89815 | TRIPRIM 200MG | tbl 10x200mg | MCK | D | |||
| 89816 | TRIPRIM 200MG | tbl 20x200mg | MCK | D | |||
| 257.3 | J01EB05 | sulfafurazol | p.o. | 4 | GM | 13,64 | |
| 258 | J01EE | sulfonamidy kombinované s trimetoprimem | p.o. | ||||
| 258.1 | J01EE01 | sulfamethoxazol a trimethoprim (pevné lékové formy, do 120 mg v jedné tabletě včetně) | p.o. | 1.92 | GM | 17,06 | |
| 258.2 | J01EE01 | Sulfamethoxazol a trimethoprim (pevné lékové formy nad 120 mg v jedné tabletě) | p.o. | 1.92 | GM | 6,84 | |
| 97868 | ORIPRIM | tbl 2x10x480mg | CAD | IND | |||
| 87758 | ORIPRIM | tbl 10x10x480mg | CAD | IND | |||
| 75023 | COTRIMOXAZOL AL FORTE | tbl 20x960mg | APA | D | |||
| 258.3 | J01EE01 | sulfamethoxazol a trimethoprim (tekuté lékové formy) | p.o. | 1.92 | GM | 22,39 | |
| 97867 | ORIPRIM PRO INFANT. | sus 100ml 240mg/5ml | CAD | IND | |||
| 91291 | SUMETROLIM | sir 100ml 240mg/5ml | EGI | H | |||
| 258.4 | J01EE03 | sulfametrol a trimethoprim (pevné lékové formy) | p.o. | 1.92 | GM | 6,94 | |
| 258.5 | J01EE03 | sulfametrol a trimethoprim (tekuté lékové formy) | p.o. | 1.92 | GM | 23,07 | |
| 258.6 | J01EE04 | sulfamonoxol a trimethoprim (pevné lékové formy) | p.o. | 1.92 | GM | 6,94 | |
| 258.7 | J01EE04 | sulfamonoxol a trimethoprim (tekuté lékové formy) | p.o. | 1.92 | GM | 23,07 | |
| 258.8 | J01EE05 | sulfadimidin a trimethoprim (pevné lékové formy) | p.o. | 1.92 | GM | 6,94 | |
| 259 | J01EE | sulfonamidy kombinované s trimetoprimem | parent. | K | |||
| 259.1 | J01EE01 | Sulfamethoxazol a trimethoprim | parent. | 1.92 | GM | 129,00 | K |
| 91281 | PRIMOTREN I.V. | inj 10x5ml | LEK | SLO | |||
| 260 | J01FA | makrolidová antibiotika | p.o. | ||||
| 260.1 | J01FA01 | erythromycin (pevné lékové formy) | p.o. | 1 | GM | 20,09 | |
| 260.2 | J01FA01 | erythromycin (tekuté lékové formy) | p.o. | 1 | GM | 47,31 | |
| 97507 | ERYTHROMYCIN-RATIO.TS 200MG/5ML | plv sus 1x60ml | MCK | D | |||
| 55585 | MEROMYCIN 200MG/5ML | plv sus 1x100ml | MCK | D | |||
| 97508 | ERYTHROMYCIN-RATIO.TS 200MG/5ML | plv sus 1x100ml | MCK | D | |||
| 55584 | MEROMYCIN 200MG/5ML | plv sus 1x60ml | MCK | D | |||
| 260.3 | J01FA02 | spiramycin | p.o. | 3 | GM | 48,42 | |
| 260.4 | J01FA05 | oleandomycin | p.o. | 1 | GM | 15,36 | |
| 260.5 | J01FA06 | roxithromycin (do 100 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 43,77 | |
| 260.6 | J01FA06 | roxithromycin (nad 100 mg v jedné tabletě) | p.o. | 0.3 | GM | 37,84 | |
| 260.7 | J01FA07 | josamycin (pevné lékové formy) | p.o. | 2 | GM | 34,05 | |
| 260.8 | J01FA07 | josamycin (tekuté lékové formy) | p.o. | 1 | GM | 42,58 | |
| 260.9 | J01FA09 | klarithromycin (pevné lékové formy) | p.o. | 0.5 | GM | 48,40 | |
| 260.10 | J01FA09 | klarithromycin (tekuté lékové formy) | p.o. | 0.5 | GM | 70,00 | |
| 260.11 | J01FA10 | azithromycin (pevné lékové formy do 125 mg v 1 tabletě nebo tobolce včetně) | p.o. | 0.25 | GM | 63,77 | |
| 260.12 | J01FA10 | azithromycin (tekuté lékové formy) | p.o. | 0.25 | GM | 86,60 | |
| 260.13 | J01FA13 | dirythromycin | p.o. | 0.5 | GM | 48,42 | |
| 260.14 | J01FA10 | azithromycin (pevné lékové formy nad 125 mg v 1 tabletě nebo tobolce) | p.o. | 0.25 | GM | 63,27 | |
| 260.15 | J01RA | kombinace antibakteriálních léčiv (spiramycin/metronidazol) | p.o. | 5 | DF | 32,16 | |
| 261 | J01FA | makrolidová antibiotika | parent. | K | |||
| 261.1 | J01FA01 | erythromycin | parent. | 1 | GM | 717,50 | K |
| 88108 | ERYTHROCIN I.V. | inj 1x300mg | ABB | GB | |||
| 261.2 | J01FA02 | spiramycin | parent. | 4,5 | MU | 663,67 | K |
| 78174 | ROVAMYCINE 1.5MU | inj sic 1x1.5mu | SPC | F | |||
| 261.3 | J01FA09 | klaritromycin | parent. | 1 | GM | 861,00 | K |
| 262 | J01FF | linkosamidová antibiotika | p.o. | ATB | |||
| 262.1 | J01FF01 | klindamycin (pevné lékové formy) | p.o. | 1.2 | GM | 55,46 | |
| 03365 | DALACIN C | cps 16x150mg | UPJ | B | |||
| 83458 | DALACIN C | cps 16x300mg | UPJ | B | |||
| 262.2 | J01FF01 | klindamycin (tekuté lékové formy) | p.o. | 1.2 | GM | 136,53 | |
| 262.3 | J01FF02 | linkomycin (pevné lékové formy) | p.o. | 1.8 | GM | 29,08 | ATB |
| 262.4 | J01FF02 | linkomycin (tekuté lékové formy) | p.o. | 1.8 | GM | 160,62 | ATB |
| 263 | J01FF | linkosamidová antibiotika | parent. | U/ATB | |||
| 263.1 | J01FF01 | klindamycin (do 0,3 GM včetně v jedné ampuli) | parent. | 1.8 | GM | 598,67 | U/ATB |
| 263.2 | J01FF01 | klindamycin (nad 0,3 GM v jedné ampuli) | parent. | 1.8 | GM | 548,92 | U/ATB |
| 263.3 | J01FF02 | linkomycin | parent. | 1.8 | GM | 49,17 | U/ATB |
| 83593 | MEDOGLYCIN 600MG | inj 100x2ml/600mg | MOE | CY | |||
| 67029 | MEDOGLYCIN 600MG | inj 10x2ml/600mg | MOE | CY | |||
| 264 | J01GA | streptomycin a jeho deriváty | parent. | ||||
| 264.1 | J01GA01 | streptomycin | parent. | 1 | GM | 119,10 | |
| 59732 | STREPTOMYCIN GRUNENTHAL 1.0 G | inj sic 1x1gm+solv. | GRU | D | |||
| 265 | J01GB | aminoglykosidová antibiotika | parent. | U/ATB | |||
| 265.1 | J01GB01 | tobramycin (do 40 mg v jedné ampuli včetně) | parent. | 0.24 | GM | 43,84 | U |
| 265.2 | J01GB01 | tobramycin (nad 40 mg v jedné ampuli) | parent. | 0.24 | GM | 23,02 | U |
| 265.3 | J01GB03 | gentamicin (do 40 mg v jedné ampuli včetně) | parent. | 0.24 | GM | 45,18 | U |
| 96413 | GENTAMICIN 40MG LEK | inj 10x2ml/40mg | LEK | SLO | |||
| 265.4 | J01GB03 | gentamicin (nad 40 mg v jedné ampuli) | parent. | 0.24 | GM | 23,61 | U |
| 96414 | GENTAMICIN 80MG LEK | inj 10x2ml/80mg | LEK | SLO | |||
| 265.5 | J01GB03 | gentamicin (lékové formy pěny) | lok. | 130 | MG | 2411,98 | U/ATB |
| 265.6 | J01GB03 | gentamicin (lékové formy kuliček k impiantaci) | imp. | 1 | DF | 152,06 | U/ATB |
| 265.7 | J01GB05 | neomycin | parent. | 1 | GM | 122,34 | U/ATB |
| 265.8 | J01GB06 | amikacin (do 100 mg v jedné ampuli včetně) | parent. | 1 | GM | 741,01 | U/ATB |
| 12334 | AMIKOZIT 100MG | inj 1x2ml | ECZ | TR | |||
| 265.9 | J01GB06 | amikacin (nad 100 mg v jedné ampuli) | parent. | 1 | GM | 398,66 | U/ATB |
| 12335 | AMIKOZIT 500MG | inj 1x2ml | ECZ | TR | |||
| 265.10 | J01GB07 | netilmicin (do 50 mg v jedné ampuli včetně) | parent. | 0.35 | GM | 519,93 | U/ATB |
| 265.11 | J01GB07 | netilmicin (nad 50 mg v jedné ampuli) | parent. | 0.35 | GM | 304,57 | U/ATB |
| 265.12 | J01GB11 | isepamicin (nad 250 mg v jedné ampuli) | parent. | 1 | GM | 516,90 | U/ATB |
| 265.13 | J01GB11 | isepamicin (do 250 mg včetně v jedné ampuli) | parent. | 1 | GM | 620,27 | U/ATB |
| 266 | J01MA | fluorované chinolony | p.o. |
K léčbě sparfloxacinem a trovafloxacinem je třeba konzultace a schválení antibiotického střediska.
Čtení tohoto dokumentu nenahrazuje čtení příslušného vydání Sbírky zákonů. Neneseme odpovědnost za případné nepřesnosti vyplývající z převodu originálu do tohoto formátu.
Tento text je zveřejněn za vlastních podmínek opětovného použití zdroje e-Sbírka, nikoli pod licencí Legalize ani pod licencí volného díla.
e-Sbírka
volné dílo (úřední díla podle § 3 písm. a) zákona č. 121/2000 Sb., autorského zákona)